May 15, 2024

Enliven has cash runway into late 2026

Enliven Therapeutics has enough cash on hand to fund operations into late 2026 and through multiple milestones for two of its drug candidate.

Lucas is an award-winning journalist who worked at news agencies from Maryland to Wyoming to South Carolina before putting roots down in Colorado.

Related Posts

Sign up for BizWest Daily Alerts
Closing in 8 seconds...